89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 170 filers reported holding 89BIO INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,410,176 | -6.4% | 3,504 | -99.2% | 0.65% | -53.3% |
Q4 2022 | $5,779,419 | +399.1% | 454,000 | +127.0% | 1.39% | +503.5% |
Q3 2022 | $1,158,000 | +44.9% | 200,000 | +509.8% | 0.23% | +560.0% |
Q4 2020 | $799,000 | -90.8% | 32,799 | -90.4% | 0.04% | -94.5% |
Q3 2020 | $8,730,000 | – | 340,236 | – | 0.63% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orchard Capital Management, LLC | 551,879 | $7,025,420 | 2.36% |
RA Capital Management | 8,955,410 | $114,002,369 | 2.31% |
Cormorant Asset Management, LP | 2,550,000 | $32,462 | 2.17% |
Deep Track Capital, LP | 3,850,000 | $49,010,500 | 2.06% |
COMMODORE CAPITAL LP | 758,244 | $9,652 | 1.46% |
Ikarian Capital, LLC | 454,000 | $5,779,419 | 1.39% |
DAFNA Capital Management LLC | 324,173 | $4,126,722 | 1.16% |
Parkman Healthcare Partners LLC | 332,880 | $4,237,562 | 1.13% |
Boxer Capital, LLC | 1,400,000 | $17,822,000 | 0.94% |
Orbimed Advisors | 3,658,869 | $46,577,402 | 0.89% |